About 10 percent of U.S. Medicare patients -- including cancer survivors -- do not take their medication because it is too expensive, Harvard researchers found. Dr. Larissa Nekhlyudov and colleagues from Harvard Medical School show cost-related medication non-adherence -- skipping pills to make the medicine last longer, and not filling in a prescription because it is too expensive -- is common among seniors. The researchers analyzed data from the 2005 Medicare Current Beneficiary Survey and Medicare claims. Nekhlyudov and the research team found no differences in the rate of cost-related non-adherence between cancer survivors and those without cancer. Six percent of cancer survivors and 9 percent of those without cancer said they spent less on basic needs -- such as food and heat -- so they could afford medicines. More than half used other cost-saving measures, including taking generic medications, requesting free samples and comparing pharmacy prices before buying drugs, Nekhlyudov says. "As the number of cancer survivors continues to increase and get older, the findings of our study enhance our understanding of the potential barriers to effective treatment of their non-cancer co-morbidities," Nekhlyudov says. The findings are published in the Journal of Cancer Survivorship.
GMT 18:32 2017 Tuesday ,19 December
new! magazine names fitness & food editorGMT 09:29 2017 Monday ,11 December
Al Ain doctors swap index finger for thumbGMT 09:26 2017 Sunday ,10 December
50 Students Poisoned by Contaminated Well Water in Central MoroccoGMT 11:39 2017 Saturday ,02 December
Round-the-clock health services provided for citizens, residentsGMT 09:44 2017 Saturday ,02 December
Age may not be why you’re sleeping badlyGMT 08:29 2017 Sunday ,26 November
Emirates Red Crescent responds to personal appeal of Yemeni nurseGMT 05:52 2017 Sunday ,19 November
AGU showcases international research in medical computer simulationGMT 13:51 2017 Saturday ,18 November
Hospital says North Korean soldier’s condition stabilizingMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2023 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2023 ©